S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94

Nu Skin Enterprises (NUS) Stock Forecast, Price & News

+1.46 (+3.24%)
(As of 05/13/2022 06:40 PM ET)
Today's Range
50-Day Range
52-Week Range
1.19 million shs
Average Volume
735,974 shs
Market Capitalization
$2.32 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

Nu Skin Enterprises logo

About Nu Skin Enterprises

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.


See More Headlines

Industry, Sector and Symbol

Drugs, proprietaries, & sundries
Personal Products
Year Founded

Sales & Book Value

Annual Sales
$2.70 billion
Cash Flow
$5.80 per share
Book Value
$18.75 per share


Net Income
$147.27 million
Pretax Margin




Free Float
Market Cap
$2.32 billion

Company Calendar

Ex-Dividend for 3/9 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 6/8 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

3.10 out of 5 stars

Consumer Staples Sector

4th out of 186 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 8 stocks

Analyst Opinion: 3.2Community Rank: 4.4Dividend Strength: 4.2Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -

Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

Is Nu Skin Enterprises a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View analyst ratings for Nu Skin Enterprises
or view top-rated stocks.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 4,110,000 shares, an increase of 45.2% from the April 15th total of 2,830,000 shares. Based on an average daily volume of 645,800 shares, the short-interest ratio is presently 6.4 days. Currently, 8.4% of the company's shares are short sold.
View Nu Skin Enterprises' Short Interest

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Nu Skin Enterprises

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) posted its quarterly earnings data on Wednesday, May, 4th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.04. The company had revenue of $604.90 million for the quarter, compared to analysts' expectations of $579.70 million. Nu Skin Enterprises had a trailing twelve-month return on equity of 22.05% and a net margin of 5.28%. The firm's revenue for the quarter was down 10.7% on a year-over-year basis. During the same period last year, the firm posted $0.91 earnings per share.
View Nu Skin Enterprises' earnings history

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Wednesday, May 4th. Shareholders of record on Friday, May 27th will be paid a dividend of $0.385 per share on Wednesday, June 8th. This represents a $1.54 dividend on an annualized basis and a yield of 3.31%. The ex-dividend date of this dividend is Thursday, May 26th.
View Nu Skin Enterprises' dividend history

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises pays an annual dividend of $1.54 per share and currently has a dividend yield of 3.31%. Nu Skin Enterprises has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Nu Skin Enterprises is 57.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 37.65% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.
View Nu Skin Enterprises' dividend history.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided EPS guidance of $3.60-$3.90 for the period, compared to the consensus estimate of $4.21. The company issued revenue guidance of $2.51 billion-$2.62 billion, compared to the consensus revenue estimate of $2.70 billion.

What price target have analysts set for NUS?

3 analysts have issued 12 month price targets for Nu Skin Enterprises' stock. Their forecasts range from $49.00 to $75.00. On average, they anticipate Nu Skin Enterprises' share price to reach $61.50 in the next twelve months. This suggests a possible upside of 32.3% from the stock's current price.
View analysts' price targets for Nu Skin Enterprises
or view top-rated stocks among Wall Street analysts.

Who are Nu Skin Enterprises' key executives?
Nu Skin Enterprises' management team includes the following people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 69, Pay $827.03k)
  • Mr. Ryan S. Napierski, Pres, CEO & Director (Age 48, Pay $1.46M)
  • Mr. Mark H. Lawrence, Exec. VP & CFO (Age 52, Pay $918.58k)
  • Dr. Joseph Y. Chang Ph.D., Exec. VP & Chief Scientific Officer (Age 69, Pay $1.13M)
  • Mr. Chayce David Clark, Exec. VP & Gen. Counsel (Age 39, Pay $540.92k)
  • Mr. Ritch N. Wood, Exec. Advisor (Age 56, Pay $1.53M) (LinkedIn Profile)
  • Mr. D. Matthew Dorny, Legal Advisor (Age 58, Pay $687.56k) (LinkedIn Profile)
  • Ms. Mang Yee Tang, Exec. VP and Chief Global Growth & Customer Experience Officer (Age 51, Pay $796.45k)
  • Mr. Blake M. Roney, Founder (Age 63)
  • Ms. Sandra N. Tillotson, Founder (Age 65)
What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises CEO Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among Nu Skin Enterprises' employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (12.04%), BlackRock Inc. (11.62%), Renaissance Technologies LLC (5.36%), Dimensional Fund Advisors LP (3.43%), Bank of New York Mellon Corp (1.65%) and Northern Trust Corp (1.39%). Company insiders that own Nu Skin Enterprises stock include Andrew D Lipman, D Matthew Dorny, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends for Nu Skin Enterprises

Which major investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including Charles Schwab Investment Management Inc., Ergoteles LLC, Acadian Asset Management LLC, Allianz Asset Management GmbH, JPMorgan Chase & Co., Prudential Financial Inc., First Trust Advisors LP, and ProShare Advisors LLC. Company insiders that have sold Nu Skin Enterprises company stock in the last year include Andrew D Lipman, D Matthew Dorny, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Ritch N Wood, and Ryan S Napierski.
View insider buying and selling activity for Nu Skin Enterprises
or view top insider-selling stocks.

Which major investors are buying Nu Skin Enterprises stock?

NUS stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., PEAK6 Investments LLC, Dimensional Fund Advisors LP, American Century Companies Inc., Renaissance Technologies LLC, Bridgewater Associates LP, BlackRock Inc., and Jackson Creek Investment Advisors LLC.
View insider buying and selling activity for Nu Skin Enterprises
or or view top insider-buying stocks.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $46.48.

How much money does Nu Skin Enterprises make?

Nu Skin Enterprises has a market capitalization of $2.32 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $2.699990 on an earnings per share basis.

How many employees does Nu Skin Enterprises have?

Nu Skin Enterprises employs 4,600 workers across the globe.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is www.nuskinenterprises.com.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at (801) 345-1000, via email at [email protected], or via fax at 801-345-5999.

This page was last updated on 5/16/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.